Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus

C. Amici,F. Lannutti,F. Superti,Mariangela Agamennone,M. Ammendolia,R. Siciliano,B. De Giulio,Agostina Pietrantoni
DOI: https://doi.org/10.1179/2047773212Y.0000000004
2012-03-01
Pathogens and Global Health
Abstract:Abstract Bovine lactoferrin (bLf) is a multifunctional glycoprotein that plays an important role in innate immunity against infections, including influenza. Here we have dissected bLf into its C- and N-lobes and show that inhibition of influenza virus hemagglutination and cell infection is entirely attributable to the C-lobe and that all major virus subtypes, including H1N1 and H3N2, are inhibited. By far-western blotting and sequencing studies, we demonstrate that bLf C-lobe strongly binds to the HA2 region of viral hemagglutinin, precisely the highly conserved region containing the fusion peptide. By molecular docking studies, three C-lobe fragments were identified which inhibited virus hemagglutination and infection at fentomolar concentration range. Besides contributing to explain the broad anti-influenza activity of bLf, our findings lay the foundations for exploiting bLf fragments as source of potential anti-influenza therapeutics.
Biology,Medicine
What problem does this paper attempt to address?